TA
CVS icon

Townsend & Associates’s CVS Health CVS Stock Holding History

Townsend & Associates’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-25,254
Closed -$1.91M – 107
2023
Q2 		$1.91M Sell
25,254
-2,177
-8% -$155K 0.49% 53
2023
Q1 		$2.01M Sell
27,431
-15,918
-37% -$1.33M 0.81% 47
2022
Q4 		$3.9M Sell
43,349
-2,234
-5% -$216K 1.93% 13
2022
Q3 		$4.63M Buy
45,583
+844
+2% +$83.5K 2.14% 6
2022
Q2 		$4.24M Sell
44,739
-267
-0.6% -$26.1K 1.96% 5
2022
Q1 		$4.8M Buy
45,006
+1,210
+3% +$127K 2.21% 4
2021
Q4 		$4.65M Sell
43,796
-19,042
-30% -$1.76M 2.55% 2
2021
Q3 		$5.3M Buy
62,838
+3,813
+6% +$319K 2.61% 3
2021
Q2 		$4.83M Buy
59,025
+40,407
+217% +$3.31M 2.82% 3
2021
Q1 		$1.4M Sell
18,618
-405
-2% -$29.5K 0.91% 46
2020
Q4 		$1.3M Sell
19,023
-1,218
-6% -$79.2K 0.95% 53
2020
Q3 		$1.2M Sell
20,241
-10,076
-33% -$627K 0.94% 56
2020
Q2 		$1.97M Sell
30,317
-3,678
-11% -$232K 1.66% 12
2020
Q1 		$1.93M Sell
33,995
-537
-2% -$35.8K 2.01% 8
2019
Q4 		$2.51M Sell
34,532
-1,020
-3% -$71.6K 2.19% 5
2019
Q3 		$2.15M Buy
35,552
+4,134
+13% +$245K 2.05% 9
2019
Q2 		$1.73M Buy
31,418
+409
+1% +$22K 1.32% 30
2019
Q1 		$1.67M Sell
31,009
-232
-0.7% -$14.3K 1.69% 27
2018
Q4 		$2.05M Buy
31,241
+600
+2% +$44.8K 2.35% 11
2018
Q3 		$2.41M Buy
+30,641
New +$2.19M 2.39% 4

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Townsend & Associates's CVS Position: Q3 2023 in Review

Townsend & Associates sold out of CVS Health (CVS) in Q3 2023, closing a stake of 25,254 shares — an estimated $1.91M sold.

Townsend & Associates first reported a position in CVS in Q3 2018 and held it in 20 quarters. The position peaked at $5.3M in Q3 2021. 2,114 funds tracked by Wall St. Rank hold CVS as of Q3 2023.

  • Townsend & Associates reported no remaining CVS Health position as of Q3 2023 after selling out during the quarter.
  • Townsend & Associates sold 25,254 CVS Health shares in Q3 2023, an estimated $1.91M.
  • Townsend & Associates first reported a position in CVS Health in Q3 2018 and held it in 20 quarters.
  • Townsend & Associates's CVS Health position peaked at $5.3M in Q3 2021.
  • 2,114 funds tracked by Wall St. Rank held CVS Health as of Q3 2023.

Based on Townsend & Associates's 13F filing for Q3 2023, filed 1 Nov 2023.